The Human VEGFR2/KDR/Flk-1 ELISA Kit (Colorimetric) measures human VEGFR2/KDR/Flk-1 in cell culture supernatant, serum, plasma (edta, citrate, heparin).
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-096951 |
|---|
| Réf. fabricant | 18200498 |
|---|
| Plage de dosage | 78 - 5000pg/mL |
|---|
| Sensibilité du dosage | 7.0pg/mL |
|---|
| Type de produit | ELISA Kit |
|---|
| Type d’échantillon | Cell Culture Supernatant, Plasma (EDTA, Citrate, Heparin), Serum |
|---|
| Spécificité | The assay detects both natural and recombinant human VEGFR2/KDR/Flk-1. Cross reactivity and interference of circulating factors of the immune system was evaluated by spiking these proteins at physiologically relevant concentrations into a human VEGFR2/KDR/Flk-1 positive sample. There was no cross reactivity detected, notably not with VEGF-R1 at physiological concentrations and not with VEGF-R3/FLT-4. There was no interference detected, notably not for VEGF-A and VEGF-C. |
|---|
| Espèces cibles | Human |
|---|
| À utiliser avec (application) | ELISA |
|---|
| Identification génétique (Entrez) | 3791 |
|---|
| Symbole de gène(s) | KDR |
|---|
| Contenus des kits | Aluminum pouch(es) with a Microwell Plate coated with monoclonal antibody to human VEGF-R2/KDR, Biotin-Conjugate anti-human VEGF-R2/KDR monoclonal antibody, Streptavidin-HRP, Human VEGF-R2/KDR Standard lyophilized, 10ng/mL upon reconstitution, Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA), Wash Buffer Concentrate 20x (PBS with 1% Tween 20), Substrate Solution (tetramethyl-benzidine), Stop Solution (1M Phosphoric acid), Adhesive Films |
|---|
| Quantité | 96 Tests |
|---|
| Disciplines de recherche | Angiogenesis, Cancer, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases |
|---|
| Conditions de stockage | Storage of components varies. See protocol for specific instructions. |
|---|
| Synonyme | CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosi |
|---|
| Cible | VEGF R2/KDR/Flk-1 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
